Neoadjuvant Treatment of Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT05947201 · UNKNOWN
Trial details
- NCT number
- NCT05947201
- Sponsor
- Weijia Fang, MD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-08
- Primary completion
- 2024-03-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.